Seneca Therapeutics: Funding, Investors & Team (Oct 2026)
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.
Seneca Therapeutics has raised $11.6M across 2 funding rounds on record, the most recent a Series B of $3.9M announced in Aug 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Seneca Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Seneca Therapeutics Funding Rounds
Seneca Therapeutics raised $7.7M in an undisclosed round announced in Jan 2023.
2.6 years later, a Series B of $3.9M was announced in Aug 2025.
Seneca Therapeutics Founders and Leadership Team
Contact details for the Seneca Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Seneca Therapeutics Funding Compared to Other Biotechnology Startups
Seneca Therapeutics' latest round of $3.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Seneca Therapeutics in Biotechnology and Blue Bell
Companies Similar to Seneca Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Seneca Therapeutics Funding FAQs
What does Seneca Therapeutics do?
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.
How much funding has Seneca Therapeutics raised?
Seneca Therapeutics has raised $11.6M across 2 rounds on record. The most recent is a Series B of $3.9M announced in Aug 2025.
When did Seneca Therapeutics last raise funding?
Seneca Therapeutics' most recent funding round on record is a Series B of $3.9M, announced in Aug 2025.
Who founded Seneca Therapeutics?
FundedIQ lists Paul Hallenbeck (Founder) at Seneca Therapeutics.
Where is Seneca Therapeutics headquartered?
Seneca Therapeutics is based in Blue Bell, Pennsylvania, United States.
How many employees does Seneca Therapeutics have?
Seneca Therapeutics is in the 11-50 employee band.
How does Seneca Therapeutics' funding compare to other Biotechnology startups?
Seneca Therapeutics' latest round of $3.9M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Seneca Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Seneca Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.